外科理论与实践 ›› 2025, Vol. 30 ›› Issue (03): 228-233.doi: 10.16139/j.1007-9610.2025.03.08
隋亮a, 陈胜b(), 刘远滨a, 黄梁a, 毛恩强a, 韩意a, 孙思磊a, 张勇a
收稿日期:
2024-06-28
出版日期:
2025-05-25
发布日期:
2025-09-01
通讯作者:
陈胜,E-mail:cs10702@rjh.com.cn
SUI Lianga, CHEN Shengb(), LIU Yuanbina, HUANG Lianga, MAO Enqianga, HAN Yia, SUN Sileia, ZHANG Yonga
Received:
2024-06-28
Online:
2025-05-25
Published:
2025-09-01
摘要:
目的 回顾性分析胆总管结石并发急性胆管炎经内镜胆管支架引流术(ERBD)、经内镜鼻胆管引流术(ENBD)或经皮经肝胆管穿刺引流术(PTCD)等微创治疗方法的效果及安全性,探讨该类疾病的微创治疗策略。方法 选取2019年1月至2020年12月我院急诊外科收治的胆总管结石并发急性胆管炎病人151例,根据包括非手术治疗方式在内的4种治疗方案将病人分为4组,比较治疗前后白细胞、胆色素、肝功能变化,以及不同手术治疗方法的术后恢复情况、并发症发生率、住院天数及预后。结果 胆总管结石并发急性胆管炎ERBD和ENBD术后白细胞计数、中性粒细胞比例、肝功能明显改善,ERBD、ENBD、PTCD术后总胆红素和直接胆红素明显下降(P<0.05)。且与保守治疗相比术后恢复快,并发症少,住院天数短,死亡率低。结论 ERBD和ENBD作为治疗胆总管结石合并急性胆管炎的微创手段,具有显著的疗效,且安全可靠,能有效提高远期微创治愈率,因此是优先选择的治疗策略。根据病人的具体情况,如感染程度、结石大小、是否口服抗凝药物等因素,临床医师可制定个体化的微创治疗方案,以确保实现最佳治疗目标。
中图分类号:
隋亮, 陈胜, 刘远滨, 黄梁, 毛恩强, 韩意, 孙思磊, 张勇. 不同胆道引流技术治疗胆总管结石并发急性胆管炎的回顾性研究[J]. 外科理论与实践, 2025, 30(03): 228-233.
SUI Liang, CHEN Sheng, LIU Yuanbin, HUANG Liang, MAO Enqiang, HAN Yi, SUN Silei, ZHANG Yong. Retroscpective studies of different biliary drainage techniques in treatment of choledocholithiasis complicated with acute cholangitis[J]. Journal of Surgery Concepts & Practice, 2025, 30(03): 228-233.
表1
治疗前各组病人情况比较[$\bar{x}\pm s$/n(%)]
Item | Treatment | χ2/z/t value | P value | ||||
---|---|---|---|---|---|---|---|
Conservative(n=7) | PTCD(n=5) | ENBD(n=31) | ERBD(n=108) | ||||
Age(years) | 78.4±9.9 | 75.6±11.9 | 72.1±12.6 | 69.4±13.5 | 1.528 | 0.210 | |
Gender | Male | 3(42.9) | 2(40.0) | 20(64.5) | 66(61.1) | 2.010 | 0.570 |
Female | 4(57.1) | 3(60.0) | 11(35.5) | 42(38.9) | |||
Complications(case) | Diabetes | 2(28.6) | 1(20.0) | 7(22.6) | 20(18.5) | 5.599 | 0.779 |
Coronary heart disease | 1(14.3) | 0 | 5(16.1) | 7(6.5) | |||
Hypertension | 1(14.3) | 3(60.0) | 16(51.6) | 46(42.6) | |||
Atrial fibrillation | 0 | 0 | 3(9.7) | 4(3.7) | |||
Temperature(℃) | 37.0±0.5 | 37.3±1.2 | 37.3±1.1 | 37.3±0.7 | 0.385 | 0.764 | |
WBC(×109/L) | 9.0±3.8 | 12.9±4.3 | 10.2±3.9 | 12.6±6..0 | 2.274 | 0.082 | |
N%(%) | 78.6±20.3 | 89.3±3.1 | 85.8±8.1 | 87.1±8.5 | 2.070 | 0.107 | |
TBil (μmol/L) | 55.5±37.1 | 123.3±45.9 | 70.7±46.5 | 99.3±94,2 | 1.619 | 0.187 | |
DBil (μmol/L) | 29.4±22.4 | 79.9±27.9 | 39.9±28.7 | 65.1±111.6 | 0.848 | 0.47 | |
ALT(IU/L) | 153.7±95.4 | 193.0±145.1 | 264.5±212.3 | 342.7±247.8 | 2.502 | 0.062 | |
AST(IU/L) | 226.7±177.6 | 205.6±109.0 | 309.8±365.0 | 364.1±334.1 | 0.816 | 0.487 | |
GGT(IU/L) | 211.1±170.7 | 475.8±463.6 | 445.5±274.6 | 514.2±399.6 | 1.582 | 0.196 | |
Severity degree | Ⅰ | 1(14.3) | 1(20.0) | 4(12.9) | 23(21.3) | 3.966 | 0.681 |
Ⅱ | 4(57.1) | 4(80.0) | 19(61.3) | 68(63.0) | |||
Ⅲ | 2(28.6) | 0(0.0) | 8(25.8) | 17(15.7) |
表3
各组治疗前、后的炎症和黄疸、肝功能指标比较($\bar{x}\pm s$)
Item | Before or after treatment | Treatment | |||
---|---|---|---|---|---|
Conservative(n=7) | PTCD(n=5) | ENBD(n=31) | ERBD(n=108) | ||
WBC(×109/L) | Before | 9.0±3.8 | 12.9±4.3 | 10.2±3.9 | 12.6±6.0 |
After | 6.8±4.7 | 10.5±5.4 | 7.2±3.6 | 8.0±4.3 | |
t value | 1.089 | 0.748 | 5.224 | 9.982 | |
P value | 0.318 | 0.496 | 0.000 | 0.000 | |
N%(%) | Before | 78.6±20.3 | 89.3±3.1 | 85.8±8.1 | 87.1±8.5 |
After | 78.8±19.9 | 80. 8±10.4 | 71.9±11.5 | 74.9±11.0 | |
t value | -0.031 | 1.677 | 6.363 | 11.085 | |
P value | 0.977 | 0.169 | 0.000 | 0.000 | |
TBil(μmol/L) | Before | 55.5±37.1 | 123.3±45.9 | 70.7±46.5 | 99.3±94.2 |
After | 57.0±45.3 | 64.1±38.2 | 41.8±30.9 | 58.0±80.5 | |
t value | -0.111 | 13.28 | 4.923 | 8.535 | |
P value | 0.915 | 0.000 | 0.000 | 0.000 | |
DBil(μmol/L) | Before | 29.4±22.4 | 79.9±27.9 | 39.9±28.7 | 65.1±111.6 |
After | 31.9±28.7 | 30.4±22.8 | 19.4±19.9 | 26.7±40.4 | |
t value | -0.216 | 12.931 | 5.316 | 3.851 | |
P value | 0.836 | 0.000 | 0.000 | 0.000 | |
ALT(IU/L) | Before | 153.7±95.4 | 193.0±145.1 | 264.5±212.3 | 342.7±247.8 |
After | 103.4±91.4 | 70.2±43.2 | 139.0±128.0 | 139.3±103.4 | |
t value | 1.305 | 2.366 | 4.65 | 9.597 | |
P value | 0.24 | 0.077 | 0.000 | 0.000 | |
AST(IU/L) | Before | 226.7±177.6 | 205.6±109.0 | 309.8±365.0 | 364.1±334.1 |
After | 93.7±95.2 | 51.0±44.9 | 91.8±105.0 | 73.7±76.4 | |
t value | 1.691 | 3.611 | 4.323 | 9.029 | |
P value | 0.142 | 0.023 | 0.000 | 0.000 | |
GGT(IU/L) | Before | 211.1±170.7 | 475.8±463.6 | 445.5±274.6 | 514.2±399.6 |
After | 163.3±118.1 | 163.3±118.1 | 313.9±190.2 | 332.3±2637 | |
t value | 2.245 | 2.377 | 5.122 | 10.383 | |
P value | 0.066 | 0.076 | 0.000 | 0.000 |
[1] | YOKOE M, HATA J, TAKADA T, et al. Tokyo guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis[J]. J Hepatobiliary Pancreat Sci, 2018, 25(1):41-54. |
[2] |
LAN CHEONG WAH D, CHRISTOPHI C, MURALIDHARAN V. Acute cholangitis: current concepts[J]. ANZ J Surg, 2017, 87(7-8):554-559.
doi: 10.1111/ans.13981 pmid: 28337833 |
[3] |
ELY R, LONG B, KOYFMAN A. The emergency medicine-focused review of cholangitis[J]. J Emerg med, 2018, 54(1):64-72.
doi: S0736-4679(17)30615-7 pmid: 28939398 |
[4] | SUGIYAMA H, TSUYUGUCHI T, SAKAI Y, et al. Current status of preoperative drainage for distalbiliary obstruction[J]. World J Hepatol, 2015, 7(18):2171-2176. |
[5] | TOHDA G, OHTANI M, DOCHIN M. Efficacy and safety of emergency endoscopic retrograde cholangiopancreatography for acute cholangitis in the elderly[J]. World J Gastroenterol, 2016, 22(37):8382-8388. |
[6] | 王平, 宋振顺, 周嘉, 等. LC+LCBDE+PS与ERCP+EST+LC 治疗胆囊结石合并胆总管结石的临床对比[J]. 肝胆胰外科杂志, 2024, 36(2):95-99. |
WANG P, SONG Z S, ZHOU J, et al. Clinical comparison of LC+LCBDE+PS and ERCP+EST+LC in the treatment of gallbladder stones combined with common bile duct stones[J]. J Hepatopancreatobiliary Surg, 2024, 36(2):95-99. | |
[7] | 吴炎炎, 燕善军, 李大鹏, 等. 回顾性研究 ERCP与LCBDE治疗胆管结石临床特点及结石复发情况[J]. 中华全科医学, 2020, 18(2):188-190,207. |
Wu Y Y, Yan S J, Li D P, et al. Retrospective study of the clinical characteristics of ERCP and LCBDE in treatment of gallbladder stones and stone recurrence[J]. Chin J Gen Pract, 2020, 18(2):188-190,207. | |
[8] | 钟家国, 赵劲松, 杨汉勇, 等. LBEPS术中一期缝合与T管引流的临床效果比较[J]. 西南国防医药, 2017, 27(7):719-721. |
ZHONG J G, ZHAO J S, YANG H Y, et al. Comparison of clinical outcomes between one-stage suturing and T-tube drainage in LBEPS surgery[J]. Med J Natl Defending Forces Southwest China, 2017, 27(7):719-721. | |
[9] | Deng M, Yan J, Zhang Z, et al. Greater than or equal to 8 mm is a safe diameter of common bile duct for primary duct closure: single-arm meta-analysis and systematic review[J]. Clin J Gastroenterol, 2022, 15(3):513-521. |
[10] |
Davidson J T 4th, Jin L X, Krasnick B, et al. Staging laparoscopy among three subtypes of extra hepatic biliary malignancy: a 15-year experience from 10 institutions[J]. J Surg Oncol, 2019, 119(3):288-294.
doi: 10.1002/jso.25323 pmid: 30586170 |
[11] | Iqbal U, Khara H S, Hu Y, et al. Emergent versus urgent ERCP in acute cholangitis: a systematic review and meta-analysis[J]. Gastrointest Endosc, 2020, 91(4):753-760. |
[12] | TINUSZ B, SZAPÁRY L, PALADI B, et al. Short course antibiotic treatment is not inferior to a long course one in acute cholangitis: a systematic review[J]. Dig Dis Sci, 2019, 64(2):307-315. |
[13] |
MUKAI S, ITOI T, BARON T H, et al. Indications and techniques of biliary drainage for acute cholangitis in updated Tokyo guidelines 2018[J]. J Hepatobiliary Pancreat Sci, 2017, 24(10):537-549.
doi: 10.1002/jhbp.496 pmid: 28834389 |
[14] | RAMCHANDANI M, PAL P, REDDY D N. Endoscopic management of acute cholangitis as a result of common bile duct stones[J]. Dig Endosc, 2017,29 Suppl 2:78-87. |
[1] | 王平, 包卉, 宋振顺. 腹腔镜胆总管探查取石联合胆囊切除术后一期缝合与T管引流临床疗效比较的荟萃分析[J]. 外科理论与实践, 2025, 30(02): 151-158. |
[2] | 翁昊, 翁明哲, 束翌俊, 顾钧, 张文杰, 王雪峰. 乳头球囊扩张及机械碎石先后顺序对ERCP治疗胆总管结石影响的前瞻性研究[J]. 外科理论与实践, 2022, 27(03): 210-214. |
[3] | 翁昊, 王雪峰. 侧视镜治疗毕Ⅱ式胃切除术后胆管结石的要领与策略[J]. 外科理论与实践, 2022, 27(03): 203-209. |
[4] | 张敏敏, 邹多武. 超声内镜在可疑胆总管结石诊治中的作用[J]. 外科理论与实践, 2022, 27(03): 193-197. |
[5] | 章波, 黄侠. 三镜联合治疗胆囊结石合并胆总管结石临床疗效及预后分析[J]. 外科理论与实践, 2021, 26(03): 254-258. |
[6] | 王宏光, 陶丽莹, 郭庆梅. 内镜逆行胰胆管造影联合SpyGlass DS胆道镜治疗胆囊颈结石和急性胆囊炎[J]. 外科理论与实践, 2020, 25(06): 481-485. |
[7] | 边大鹏, 冯秋实. 复发胆总管结石伴随十二指肠乳头疾病的分析[J]. 外科理论与实践, 2020, 25(06): 477-480. |
[8] | 王申捷, 毛志海, 郑民华. 胆囊结石合并胆总管结石时的一期治疗临床研究:术中ERCP与腹腔镜胆总管探查术的比较[J]. 外科理论与实践, 2020, 25(01): 65-68. |
[9] | 陆晔, 刘皓慈, 陈胜, 吴卫泽,. ERCP联合EST治疗胆总管结石的术后远期并发症[J]. 外科理论与实践, 2015, 20(02): 116-120. |
[10] | 吕美凤, 刘连勇,. 以腹痛为首发症状的原发性甲状旁腺功能亢进漏诊1例[J]. 内科理论与实践, 2014, 9(06): 420-421. |
[11] | 侯晓敏, 葛步军,. 腹腔镜胆总管取石和内镜乳头切开取石治疗胆总管结石的回顾性分析[J]. 外科理论与实践, 2013, 18(06): 561-566. |
[12] | 王广义, 邱伟, 吕国悦,. 胆囊结石合并胆总管结石的微创治疗[J]. 外科理论与实践, 2013, 18(02): 112-115. |
[13] | 林天龙, 毛志海, 张卓, 王明亮, 郑民华,. 腹腔镜胆囊切除术中联合ERCP治疗胆囊结石合并肝外胆管结石[J]. 外科理论与实践, 2011, 16(06): 541-544. |
[14] | 郭伟, 韩威, 金岚, 刘军, 赵晓牧, 李建设, 张忠涛, 王宇,. 腹腔镜联合术中经胆囊管胆道镜辅助胆管探查取石术(附546例报告)[J]. 外科理论与实践, 2011, 16(04): 359-361. |
[15] | 李奇为, 曹亦军,. EST术后胆总管结石复发的内镜处理疗效分析[J]. 外科理论与实践, 2010, 15(03): 289-290. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||